RxDoctor Payments Data

Laura Hansen, DO

Family Medicine · Hondo, TXNPI 1275920506

Payments from drug & device makers

$1,736in general payments, 2019–2025

Across 113 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$702
  • Novo Nordisk$264
  • AstraZeneca$206
  • GSK$111
  • Merck$97
  • Amgen$64
  • plus $291 from 12 others

What the payments were for

  • Food & beverage$1,736100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,736 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$4,994
Medicare patients
13
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$81,303
RybelsusSemaglutide51$62,398
EliquisApixaban80$57,588
TrulicityDulaglutide30$37,501
XareltoRivaroxaban50$36,224
FarxigaDapagliflozin Propanediol30$35,008
JardianceEmpagliflozin50$33,659
MounjaroTirzepatide25$29,880
VraylarCariprazine Hcl19$29,780
JanuviaSitagliptin Phosphate16$21,458
ProliaDenosumab11$18,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$18,754
LinzessLinaclotide16$8,258
JanumetSitagliptin Phos/Metformin Hcl12$6,205
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,820

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Levemir$264$146,243137 claims
Lilly USA, LLCTrulicity, Mounjaro$53$67,38255 claims
PfizerEliquis$36$57,58880 claims
AbbVieVraylar, Linzess, Synthroid$702$39,88868 claims
AstraZenecaFarxiga$206$35,00830 claims
MerckJanuvia, Janumet$97$27,66328 claims
AmgenProlia$64$18,83411 claims
GSKTrelegy Ellipta$111$18,75425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Hondo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →